Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Pregabalin
Teva B.V.
N03A
Pregabalin
75 milligram(s)
Capsule, hard
Oral use
e blisters of 14, 14x1, 50x1, 56, 56x1, 60, 70, 90, 100, 100x1 or 120 capsules.
Product subject to prescription which may not be renewed (A)
TEVA UK Ltd, Merckle GmbH, PLIVA Hrvatska d.o.o. (PLIVA Croatia Ltd.)
Antiepileptics, other antiepileptics
ANTIEPILEPTICS
It is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. andfor the treatment of Generalised Anxiety Disorder (GAD) in adults
Marketed
2015-07-24
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT PREGABALIN TEVA 25 MG CAPSULES, HARD PREGABALIN TEVA 50 MG CAPSULES, HARD PREGABALIN TEVA 75 MG CAPSULES, HARD PREGABALIN TEVA 100 MG CAPSULES, HARD PREGABALIN TEVA 150 MG CAPSULES, HARD PREGABALIN TEVA 200 MG CAPSULES, HARD PREGABALIN TEVA 300 MG CAPSULES, HARD pregabalin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Pregabalin Teva is and what it is used for 2. What you need to know before you take Pregabalin Teva 3. How to take Pregabalin Teva 4. Possible side effects 5. How to store Pregabalin Teva 6. Contents of the pack and other information 1. WHAT PREGABALIN TEVA IS AND WHAT IT IS USED FOR Pregabalin Teva belongs to a group of medicines used to treat epilepsy, neuropathic pain and Generalised Anxiety Disorder (GAD) in adults. PERIPHERAL AND CENTRAL NEUROPATHIC PAIN: Pregabalin Teva is used to treat long lasting pain caused by damage to the nerves. A variety of diseases can cause peripheral neuropathic pain, such as diabetes or shingles. Pain sensations may be described as hot, burning, throbbing, shooting, stabbing, sharp, cramping, aching, tingling, numbness, pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbance, fatigue (tiredness), and can have an impact on physical and social functioning and overall quality of life. EPILEPSY: Pregabalin Teva is used to treat a certain form of epilepsy (partial seizures with or without secondary generalisation) in adults. Your doctor will p Lugege kogu dokumenti
Health Products Regulatory Authority 22 March 2024 CRN00F3HZ Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pregabalin Teva 75 mg capsules, hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule, hard contains 75 mg of pregabalin. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, hard. Pregabalin Teva 75 mg are opaque hard gelatine size 3 capsules with overall closed length 15.9 mm ± 0.3 mm, with pink cap and ivory body imprinted by black sign 75, filled with white to off-white granulated powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Neuropathic pain_ Pregabalin Teva is indicated for the treatment of peripheral and central neuropathic pain in adults. _Epilepsy_ Pregabalin Teva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. _Generalised anxiety disorder_ Pregabalin Teva is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dose range is 150 to 600 mg per day given in either two or three divided doses. _Neuropathic pain_ Pregabalin treatment can be started at a dose of 150 mg per day given as two or three divided doses. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after an interval of 3 to 7 days, and if needed, to a maximum dose of 600 mg per day after an additional 7-day interval. _Epilepsy_ Pregabalin treatment can be started with a dose of 150 mg per day given as two or three divided doses. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after 1 week. The maximum dose of 600 mg per day may be achieved after an additional week. _Generalised anxiety disorder_ The dose range is 150 to 600 mg per day given as two or three divided doses. The need for treatment should be reassessed regularly. Pregabalin treatment can be started with a dose of 150 mg per day. Based on individual patient resp Lugege kogu dokumenti